<?xml version="1.0" standalone="yes"?>
<!-- extract of the VMD Product Information Database snapshot of 01/10/2026 -->
<VMD_PIDProducts>
  <CurrentAuthorisedProducts>
    <VMDProductNo>A010412</VMDProductNo>
    <Name>Oxmax 65 mg/ml Solution for Infusion for Dogs</Name>
    <MAHolder>New Alpha Innovation Biopharmaceutical Ireland Limited</MAHolder>
    <Distributors>&lt;span&gt;New Alpha Innovation Biopharmaceutical Ireland Limited&lt;/span&gt;</Distributors>
    <VMNo>51132/5000</VMNo>
    <DateOfIssue>2023-11-28</DateOfIssue>
    <AuthorisationRoute>National</AuthorisationRoute>
    <Territory>Great Britain</Territory>
    <ActiveSubstances>Hemoglobin betafumaril (bovine) </ActiveSubstances>
    <ControlledDrug>N</ControlledDrug>
    <TargetSpecies>Dogs</TargetSpecies>
    <DistributionCategory>POM-V</DistributionCategory>
    <PharmaceuticalForm>Solution for infusion</PharmaceuticalForm>
    <TherapeuticGroup>Replacement Agent</TherapeuticGroup>
    <SPC_Link>https://www.vmd.defra.gov.uk/productinformationdatabase/files/SPC_Documents/SPC_2678081.PDF</SPC_Link>
    <UKPAR_Link>https://www.vmd.defra.gov.uk/productinformationdatabase/files/UKPAR_Documents/UKPAR_2732771.PDF</UKPAR_Link>
    <PAAR_Link />
  </CurrentAuthorisedProducts>
</VMD_PIDProducts>
